Breaking New Ground in Alzheimer’s Disease Therapeutics The landscape of Alzheimer’s disease (AD) therapeutics has undergone remarkable transformation in recent years. Following decades of limited progress, researchers and clinicians are now witnessing an unprecedented surge in promising treatment approaches. This renaissance stems from deeper insights into disease mechanisms and innovative therapeutic strategies that target multiple Read.